Modified biological hybrid nanoplatform for curcumin delivery and fe 3 ⁺ sensing to reverse CAF-derived QSOX1-mediated cisplatin resistance in esophageal squamous cell carcinoma
A multifunctional nanoplatform was developed to integrate targeted drug delivery with tumor microenvironment modulation and exhibited pH-responsive drug release behavior and intrinsic Fe 3 ⁺ sensing capability, providing an auxiliary function for monitoring tumor microenvironment-related biochemical changes.